论文部分内容阅读
目的:临床分析普米克令舒结合孟鲁司特在哮喘治疗中的应用效果。方法:临床选取我院在2013年3月-2014年3月实施治疗的100例哮喘患者,将其均分成两组,其中对照组患者单纯实施普米克令舒治疗,观察组在此基础上加上孟鲁司特治疗。对比两组患者临床疗效。结果:观察组患者的的临床症状缓解时间和肺部体征消失时间和对照组相比,明显偏少,差异显著(P<0.05);观察组患者的临床治疗总有效率为90%,明显高于对照组患者的68%,差异显著(P<0.05);对照组患者临床治疗不良反应发生率高于观察组,但是两者之间差异比较,不具有统计学意义(P>0.05)。结论:普米克令舒结合孟鲁司特在哮喘治疗中应用,能够取得良好的临床治疗效果,值得在临床中进行推广使用。
Objective: To analyze the clinical effect of pulmicort and montelukast in the treatment of asthma. Methods: A total of 100 asthma patients who were treated in our hospital from March 2013 to March 2014 were selected and divided into two groups. Patients in the control group were treated with pulmicort alone. On the basis of this, On montelukast treatment. The clinical efficacy of two groups were compared. Results: Compared with the control group, the remission time and the disappearance time of lung signs in the observation group were significantly less than those in the control group (P <0.05). The total effective rate in the observation group was 90%, significantly higher (P <0.05). The incidence of adverse reactions in the control group was higher than that in the observation group, but the difference between the two groups was not statistically significant (P> 0.05). Conclusion: Pulmicort respules combined with montelukast in the treatment of asthma can achieve good clinical curative effect and is worth popularizing in the clinic.